Search Results - "Adaui, V"

Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony by Adaui, V, Schnorbusch, K, Zimic, M, Gutiérrez, A, Decuypere, S, Vanaerschot, M, DE Doncker, S, Maes, I, Llanos-Cuentas, A, Chappuis, F, Arévalo, J, Dujardin, J-C

“…Evaluation of Leishmania drug susceptibility depends on in vitro Sb(V) susceptibility assays, which are labour-intensive and may give a biased view of the true…”
Get more information

Controversial role of leishmania RNA virus as a determinant of pathogenicity in human leishmaniasis by Valencia, B, Jara, M, Adaui, V, Chantry, M, Alba, M, Ramos, A, Arevalo, J, Llanos-Cuentas, A, Boggild, A.K

Get full text

Proviral load and immune markers associated with human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru by Best, I., Adaui, V., Verdonck, K., González, E., Tipismana, M., Clark, D., Gotuzzo, E., Vanham, G.

“…Summary Human T‐lymphotropic virus type 1 (HTLV‐1) is the aetiological agent of HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). The…”
Get full text

Putative markers of infective life stages in Leishmania (Viannia) braziliensis by Gamboa, D, Van Eys, G, Victoir, K, Torres, K, Adaui, V, Arevalo, J, Dujardin, J-C

“…Gene expression is known to vary significantly during the Leishmania life-cycle. Its monitoring might allow identification of molecular changes associated with…”
Get more information

Influence of Leishmania (Viannia) Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis by Arevalo, Jorge, Ramirez, Luis, Adaui, Vanessa, Zimic, Mirko, Tulliano, Gianfranco, Miranda-Verástegui, César, Lazo, Marcela, Loayza-Muro, Raúl, De Doncker, Simonne, Maurer, Anne, Chappuis, Francois, Dujardin, Jean-Claude, Llanos-Cuentas, Alejandro

“…Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary leishmaniasis (ATL). There are, however, reports of the…”
Get full text

American Tegumentary Leishmaniasis: Is Antimonial Treatment Outcome Related to Parasite Drug Susceptibility? by Yardley, Vanessa, Ortuño, Nimer, Llanos-Cuentas, Alejandro, Chappuis, François, De Doncker, Simonne, Ramirez, Luis, Croft, Simon, Arevalo, Jorge, Adui, Vanessa, Bermudez, Hernan, Decuypere, Saskia, Dujardin, Jean-Claude

“…BackgroundAntimonials are the first drug of choice for the treatment of American tegumentary leishmaniasis (ATL); however, their efficacy is not predictable,…”
Get full text

SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: Influence of clinical status, sex, and familial relatedness by Adaui, Vanessa, Verdonck, Kristien, Best, Iván, González, Elsa, Tipismana, Martín, Arévalo, Jorge, Vanham, Guido, Campos, Miguel, Zimic, Mirko, Gotuzzo, Eduardo

“…To evaluate the human T-lymphotropic virus type 1 (HTLV-1) proviral DNA load in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis…”
Get full text